News

Amgen has ‘a lot to prove’ in the weight-loss drug category, says Mizuho’s Jared Holz

February 8, 2024

Jared Holz, Mizuho, joins ‘Closing Bell Overtime’ to talk Amgen’s obesity drug trial results.

 

Mizuho news from around the globe
Mizuho Global News
Back to top